TAK-700(CAS: 426219-18-3)

TAK-700 (CAS: 426219-18-3) is a small molecule drug candidate developed by Takeda Pharmaceutical Company. It is a selective inhibitor of phosphodiesterase 4 (PDE4) with potential anti-inflammatory and immunomodulatory properties.

TAK-700 (CAS: 426219-18-3) is primarily used in the treatment of chronic obstructive pulmonary disease (COPD) and is being evaluated for other inflammatory conditions such as psoriasis and rheumatoid arthritis.

TAK-700 (CAS: 426219-18-3) is generally considered safe when used as directed. However, it may cause side effects such as gastrointestinal issues, headache, and respiratory symptoms. Proper medical supervision and adherence to recommended dosages are crucial.

TAK-700 (CAS: 426219-18-3) should be stored at room temperature (15-30°C) and protected from light. It should be kept in a tightly closed container to prevent moisture and other contaminants. Avoid exposure to high temperatures and ensure proper labeling and storage conditions to maintain its efficacy and safety.